A polymorphism in the gene encoding apolipoprotein L1 (APOL1) has been associated with the development of several nephropathies, including hypertension-attributed nephropathy, and glomerulopathies like HIV-associated nephropathy (HIVAN) and idiopathic FSGS. This evidence concerns the gene APOL1 and lipoprotein glomerulopathy.